Human epo receptor agonists, compositions, methods and uses...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/4745 (2006.01) A61K 31/506 (2006.01) A61K 38/16 (2006.01) A61K 38/22 (2006.01) A61K 47/48 (2006.01) A61P 3/10 (2006.01) C07K 14/505 (2006.01) C07K 16/22 (2006.01) C12N 5/00 (2006.01)

Patent

CA 2665037

The present invention relates to at least one human EPO receptor agonist methods for preventing or treating glucose intolerance and/or renal disease associated anemia, including therapeutic compositions, methods and devices.

La présente invention concerne au moins un procédé agoniste de récepteur de EPO humain pour empêcher ou traiter une intolérance au glucose et/ou une maladie rénale associée à une anémie, ainsi que des compositions thérapeutiques, des procédés et des dispositifs.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Human epo receptor agonists, compositions, methods and uses... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human epo receptor agonists, compositions, methods and uses..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human epo receptor agonists, compositions, methods and uses... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1473322

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.